ODT’s Most-Read Stories This Week—Oct. 26

Artificial intelligence and machine learning are everywhere these days.

While the technologies figure prominently in musculoskeletal health now, they can be equally as transformative in product marketing. An online exclusive exploring both technologies’ roles in orthopedic marketing strategies took top (traffic) honors this past week on ODT’s website.

Cybervisitors also found favor in the latest hip, knee, and shoulder innovation and personnel news. Medacta scored runner-up status to the digital marketing report by launching its Hip Revision Platform in the European market and introducing a simplified approach to ACL correction.

The company’s expanded Hip Revision Platform features a complete femoral and acetabular portfolio designed to address various levels of surgical complexity, supported by a medical education program delivered by esteemed Key Opinion Leaders. Its M-ARS (Medacta – Anatomic Ribbon Surgery) anterior cruciate ligament (ACL) technique, meanwhile, offers a more natural approach to ACL reconstruction than traditional round-graft-tunnel single-bundle solutions. It is designed to optimize knee biomechanics and enhance graft healing following ACL reconstruction, mimicking the native footprint by using a flat graft to enhance stress distribution and biological healing at the insertion site, potentially improving recovery time and patients’ return to an active lifestyle.

Catalyst OrthoScience drove site traffic with its latest personnel news, and RevBio produced plenty of pageviews with word of its $2.4 million National Institutes of Health grant that will fund a study of its bone adhesive biomaterial.

1. The Role of Digital Innovation in Shaping Orthopedic Marketing Strategies
2. Medacta Launches Extended Enhancements to Hip Revision Platform
3. NIH Awards RevBio $2.4M Grant for Regenerative Bone Adhesive Trial
4. Catalyst Ortho Promotes Dr. Amy Ables to Chief Commercial Officer
5. Simplified Approach to ACL Reconstruction Unveiled